Detalhe da pesquisa
1.
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication.
J Hepatol
; 66(3): 485-493, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27780714
2.
Influence of universal HBV vaccination on chronic HBV infection in Italy: Results of a cross-sectional multicenter study.
J Med Virol
; 89(12): 2138-2143, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28608566
3.
Simeprevir and daclatasvir for 12 or 24 weeks in treatment-naïve patients with hepatitis C virus genotype 1b and advanced liver disease.
Liver Int
; 37(9): 1304-1313, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28135777
4.
Management of hepatitis C virus genotype 4: recommendations of an international expert panel.
J Hepatol
; 54(6): 1250-62, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21316497
5.
Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study.
J Med Virol
; 81(12): 1999-2006, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19856477
6.
Chronic hepatitis B in Italy: new features of an old disease--approaching the universal prevalence of hepatitis B e antigen-negative cases and the eradication of hepatitis D infection.
Clin Infect Dis
; 46(1): 110-3, 2008 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18171224
7.
Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C.
Haematologica
; 93(8): 1243-6, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18556410
8.
Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy.
Eur J Gastroenterol Hepatol
; 30(6): 676-681, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29465473
9.
Rivaroxaban-induced hepatotoxicity: review of the literature and report of new cases.
Eur J Gastroenterol Hepatol
; 30(2): 226-232, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29120909
10.
Etiological factors of chronic hepatitis in Italy: a 2014 national survey.
Eur J Gastroenterol Hepatol
; 29(9): 994-997, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28538268
11.
Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and without cirrhosis with chronic hepatitis C virus genotype 1, 2, or 3 infection (C-CREST-1 and C-CREST-2, part B): two randomised, phase 2, open-label trials.
Lancet Gastroenterol Hepatol
; 2(11): 814-823, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28802814
12.
Management of hepatitis B virus infection in the underprivileged world.
Liver Int
; 31(6): 749-50, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21645204
13.
HALT-C in the final analysis: a molehill out of a mountain.
J Hepatol
; 50(6): 1280-2, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19398229
14.
IL-10 and TNF-alpha polymorphisms and the recovery from HCV infection.
Hum Immunol
; 64(7): 674-80, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12826369
15.
Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: a retrospective cohort study.
Dig Liver Dis
; 46(12): 1116-20, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25224696
16.
Serology in adults with celiac disease: limited accuracy in patients with mild histological lesions.
Intern Emerg Med
; 7(4): 337-42, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21468695
17.
Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature.
Clin Rev Allergy Immunol
; 42(3): 288-97, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21188646
18.
Pegylated-interferon-α(2a) in clinical practice: how to manage patients suffering from side effects.
Expert Opin Drug Saf
; 10(3): 429-35, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21323500
19.
The optimal dose of ribavirin for chronic hepatitis C: From literature evidence to clinical practice: The optimal dose of ribavirin for chronic hepatitis C.
Hepat Mon
; 11(4): 240-6, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22087150
20.
Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virus.
Hepat Med
; 3: 21-8, 2011 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24367218